Water

Water

SCHEMBL4082000

C[N+]1(Cc2ccccc2)CCOCC1.[OH-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 2/20 0.47
APOBEC3G Q9HC16 2/20 0.47
CYP2D6 P10635 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
CHRNA7 P36544 7/20 0.42
CHRNB2 P17787 3/20 0.42
CHRNA4 P43681 3/20 0.42
CHRNA3 P32297 2/20 0.42
CHRNB4 P30926 1/20 0.42
CCR5 P51681 2/20 0.42
ACHE P22303 4/20 0.40
CHRM3 P20309 1/20 0.39
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
RAD52 P43351 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1961848 0.98 APOBEC3A (0.48) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
Bromide SCHEMBL10751445 0.96 APOBEC3A (0.47) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
SCHEMBL10257015 0.96 APOBEC3A (0.47) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
Hydrochloric Acid SCHEMBL10751415 0.96 APOBEC3A (0.47) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
Water SCHEMBL3683454 0.82 CHRNA7 (0.58) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
SCHEMBL12682901 0.81 CHRNA7 (0.44) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
Water SCHEMBL723735 0.80 CHRNB2 (0.59) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
Water SCHEMBL8939227 0.80 CHRNB2 (0.59) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
SCHEMBL3681307 0.79 CHRNA7 (0.60) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7
SCHEMBL20017727 0.79 CHRNA7 (0.43) APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504527-B2 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING, LLC (US) 2009-03-17 US disclosed
US-7491837-B2 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING LLC. (US) 2009-02-17 US disclosed
US-7145029-B2 Low corrosive integrated process for preparing dialkyl carbonates EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-12-05 US disclosed
EP-1490323-A1 A LOW CORROSIVE INTEGRATED PROCESS FOR PREPARING DIALKYL CARBONATES ExxonMobil Chemical Patents, Inc., A Corporation of the State of Delaware (US) 2004-12-29 EP disclosed
US-20040236136-A1 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING, LLC 2004-11-25 US disclosed
US-6774256-B2 Low corrosive integrated process for preparing dialkyl carbonates EXXONMOBIL CHEMICAL PATENTS INC. 2004-08-10 US disclosed
US-20040059083-A1 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING, LLC 2004-03-25 US disclosed
US-20040054214-A1 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING, LLC 2004-03-18 US disclosed
WO-2003082797-A1 A LOW CORROSIVE INTEGRATED PROCESS FOR PREPARING DIALKYL CARBONATES EXXONMOBIL CHEMICAL PATENTS INC. A CORPORATION OF THE STATE OF DELAWARE (US) 2003-10-09 WO disclosed
US-20030023109-A1 Low corrosive integrated process for preparing dialkyl carbonates BADGER LICENSING, LLC 2003-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236136-A1 Low corrosive integrated process for preparing dialkyl carbonates DCLK1, DGKI, GALK1 APOBEC3A 409/4885APOBEC3G 493/4885CYP2D6 1273/4885
US-20040054214-A1 Low corrosive integrated process for preparing dialkyl carbonates DCLK1, DGKI, GALK1 APOBEC3A 409/4885APOBEC3G 493/4885CYP2D6 1273/4885
US-20030023109-A1 Low corrosive integrated process for preparing dialkyl carbonates DCLK1, DGKI, GALK1 APOBEC3A 409/4885APOBEC3G 493/4885CYP2D6 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.